Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 035 056.7 |
96 | EP file number | EAKZ | 04 81 1377.3 |
86 | WO file number | WAKZ | PCT/US2004/038650 |
97 | EP publication number | EPN | 1684719 |
87 | WO publication number | WPN | 2005048985 |
54 | Designation/title | TI | ALPHA1-ANTITRYPSIN-ZUSAMMENSETZUNGEN UND BEHANDLUNGSVERFAHREN UNTER VERWENDUNG DIESER ZUSAMMENSETZUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 9/12 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 11/00 (2006.01) |
22 | DE application date | DAT | Nov 11, 2004 |
96 | EP application date | EAT | Nov 11, 2004 |
86 | WO application date | WAT | Nov 11, 2004 |
43 | Date of first publication | OT | Jun 2, 2005 |
| Date of publication of grant | PET | Oct 26, 2011 |
71/73 | Applicant/owner | INH | Arriva Pharmaceuticals, Inc., Alameda, Calif., US; Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US |
72 | Inventor | IN | KABINGUE, Ken, Los Angeles, CA 90041, US; BARR, Philip J., Oakland, CA 94619, US; DURRANI, Manzer J., Plantation, FL 33322, US; BATHURST, Ian C., Alameda, CA 94501, US; KREIGER, Timothy, Lowell, MA 01854, US; KUMAR, Harish, Fullerton, CA 92833, US; MOSHER, Virginia, Lebanon, MO 65536, US |
74 | Representative | VTR | Wuesthoff & Wuesthoff, Patentanwälte PartG mbB, 81541 München, DE |
| Address for service | | Wuesthoff & Wuesthoff Patentanwälte PartG mbB, 81541 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 520549 P Nov 14, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, AL, HR, LV, MK, YU |
| Published EP/WO documents | EPWOPN | Original document:
EP000001684719 Searchable text:
EP000001684719 Original document:
EP000001684719B1 Searchable text:
EP000001684719B1 Original document:
WO002005048985 Searchable text:
WO002005048985 |
43 | Date of first publication | EVT | Jun 2, 2005 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 26, 2020 (Show all update days)(Hide all update days)- Aug 26, 2020; Jul 20, 2020; Jun 4, 2020; Jun 3, 2020; Oct 30, 2018; Oct 24, 2018; Oct 25, 2017; Sep 15, 2017; Aug 31, 2017; Jul 25, 2017; Dec 1, 2016; Dec 9, 2015; Oct 26, 2015; Apr 29, 2015; Dec 14, 2014; Dec 9, 2014; Dec 12, 2013; Dec 10, 2013; Jan 28, 2013; Dec 15, 2012; Dec 5, 2012; Nov 29, 2012; Apr 4, 2012; Mar 27, 2012; Mar 24, 2012; Mar 22, 2012; Feb 3, 2012; Jan 24, 2012; Jan 21, 2012; Dec 15, 2011; Dec 6, 2011; Oct 28, 2011; Oct 27, 2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 27, 2011 |
| Issue number | HN | 35 |
| Year | PJ | 2017 |
| Publication date | VT | Aug 31, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Arriva Pharmaceuticals, Inc., Alameda, Calif., US; Baxter Healthcare SA, Zürich, CH; Baxter International Inc., Deerfield, Ill., US |
71/73 | Previous applicant/owner | INHF | Baxter International Inc., Deerfield, Ill., US, Baxter Healthcare S.A., 8304 Wallisellen, CH, Arriva Pharmaceuticals, Inc., Alameda, Calif., US |
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 24, 2017 |
| Issue number | HN | 35 |
| Year | PJ | 2017 |
| Publication date | VT | Aug 31, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Arriva Pharmaceuticals, Inc., Alameda, Calif., US; Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Inc., Bannockburn, Ill., US |
71/73 | Previous applicant/owner | INHF | Arriva Pharmaceuticals, Inc., Alameda, Calif., US, Baxter Healthcare SA, Zürich, CH, Baxter International Inc., Deerfield, Ill., US |
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 14, 2017 |
| Issue number | HN | 43 |
| Year | PJ | 2017 |
| Publication date | VT | Oct 26, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Arriva Pharmaceuticals, Inc., Alameda, Calif., US; Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US |
71/73 | Previous applicant/owner | INHF | Arriva Pharmaceuticals, Inc., Alameda, Calif., US, Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Inc., Bannockburn, Ill., US |